|
1
|
Kopecek J: Polymer-drug conjugates:
Origins, progress to date and future directions. Adv Drug Deliv
Rev. 65:49–59. 2013. View Article : Google Scholar
|
|
2
|
Larson N and Ghandehari H: Polymeric
conjugates for drug delivery. Chem Mater. 24:840–853. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li J, Yu F, Chen Y and Oupicky D:
Polymeric drugs: Advances in the development of pharmacologically
active polymers. J Control Release. 219:369–382. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khandare J and Minko T: Polymer-drug
conjugates: Progress in polymeric prodrugs. Prog Polym Sci.
31:359–397. 2006. View Article : Google Scholar
|
|
5
|
Li C and Wallace S: Polymer-drug
conjugates: Recent development in clinical oncology. Adv Drug Deliv
Rev. 60:886–898. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng Q and Tong R: Anticancer
nanoparticulate polymer-drug conjugate. Bioeng Transl Med.
1:277–296. 2016.PubMed/NCBI
|
|
7
|
Canal F, Sanchis J and Vicent MJ:
Polymer-drug conjugates as nano-sized medicines. Curr Opin
Biotechnol. 22:894–900. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee BS, Vert M and Holler E: Water-soluble
aliphatic polyesters: Poly(malic acid)s. Wiley-VCH Verlag GmbH
& Co KGaA. 2005.
|
|
9
|
Braud C, Bunel C and Vert M: Poly(β-malic
acid): A new polymeric drug-carrier. Polymer Bulletin. 13:293–299.
1985. View Article : Google Scholar
|
|
10
|
Loyer P and Cammas-Marion S: Natural and
synthetic poly(malic acid)-based derivates: A family of versatile
biopolymers for the design of drug nanocarriers. J Drug Target.
22:556–575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fernández CE, Mancera M, Holler E, Galbis
JA and Muñoz-Guerra S: High molecular weight methyl ester of
microbial poly(β,l-malic acid): Synthesis and crystallization.
Polymer. 47:6501–6508. 2006. View Article : Google Scholar
|
|
12
|
Martinez Barbosa ME, Cammas S, Appel M and
Ponchel G: Investigation of the degradation mechanisms of
poly(malic acid) esters in vitro and their related cytotoxicities
on J774 macrophages. Biomacromolecules. 5:137–143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Segal E and Satchi-Fainaro R: Design and
development of polymer conjugates as anti-angiogenic agents. Adv
Drug Deliv Rev. 61:1159–1176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ljubimova JY, Portilla-Arias J, Patil R,
Ding H, Inoue S, Markman JL, Rekechenetskiy A, Konda B, Gangalum
PR, Chesnokova A, et al: Toxicity and efficacy evaluation of
multiple targeted polymalic acid conjugates for triple-negative
breast cancer treatment. J Drug Target. 21:956–967. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee BS, Fujita M, Khazenzon NM, Wawrowsky
KA, Wachsmann-Hogiu S, Farkas DL, Black KL, Ljubimova JY and Holler
E: Polycefin, a new prototype of a multifunctional nano-conjugate
based on poly(beta-L-malic acid) for drug delivery. Bioconjug Chem.
17:317–326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding H, Inoue S, Ljubimov AV, Patil R,
Portilla-Arias J, Hu J, Konda B, Wawrowsky KA, Fujita M, Karabalin
N, et al: Inhibition of brain tumor growth by intravenous poly
(beta-L-malic acid) nanobioconjugate with pH-dependent drug release
[corrected]. Proc Natl Acad Sci USA. 107:18143–18148. 2010.
View Article : Google Scholar
|
|
17
|
Qiao YB, Duan X, Fan L, Li W, Wu H and
Wang YK: Synthesis of controlled molecular weight poly (beta-malic
acid) and conjugation with HCPT as a polymeric drug carrier. J
Polym Res. 21:3972014. View Article : Google Scholar
|
|
18
|
Yang T, Li W, Duan X, Zhu L, Fan L, Qiao Y
and Wu H: Preparation of two types of polymeric micelles based on
poly(beta-L-malic acid) for antitumor drug delivery. PLoS One.
11:e01626072016. View Article : Google Scholar
|
|
19
|
Guo X, Shi C, Wang J, Di S and Zhou S:
pH-triggered intracellular release from actively targeting polymer
micelles. Biomaterials. 34:4544–4554. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen B, Dai W, He B, Zhang H, Wang X, Wang
Y and Zhang Q: Current multistage drug delivery systems based on
the tumor microenvironment. Theranostics. 7:538–558. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang X, Liao W, Zhang G, Kang S and Zhang
CY: pH-sensitive micelles self-assembled from polymer brush
(PAE-g-cholesterol)- b-PEG-b-(PAE-g-cholesterol) for anticancer
drug delivery and controlled release. Int J Nanomedicine.
12:2215–2226. 2017. View Article : Google Scholar :
|
|
22
|
Wang X, Yang Y, Zhuang Y, Gao P, Yang F,
Shen H, Guo H and Wu D: Fabrication of pH-responsive nanoparticles
with an AIE feature for imaging intracellular drug delivery.
Biomacromolecules. 17:2920–2929. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao D, Xu JQ, Yi XQ, Zhang Q, Cheng SX,
Zhuo RX and Li F: pH-activated targeting drug delivery system based
on the selective binding of phenylboronic acid. ACS Appl Mater
Interfaces. 8:14845–14854. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun T, Zhang YS, Pang B, Hyun DC, Yang M
and Xia Y: Engineered nanoparticles for drug delivery in cancer
therapy. Angew Chem Int Ed Engl. 53:12320–12364. 2014.PubMed/NCBI
|
|
25
|
Karimi M, Eslami M, Sahandi-Zangabad P,
Mirab F, Farajisafiloo N, Shafaei Z, Ghosh D, Bozorgomid M,
Dashkhaneh F and Hamblin MR: pH-sensitive stimulus-responsive
nanocarriers for targeted delivery of therapeutic agents. Wiley
Interdiscip Rev Nanomed Nanobiotechnol. 8:696–716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qian CG, Chen YL, Feng PJ, Xiao XZ, Dong
M, Yu JC, Hu QY, Shen QD and Gu Z: Conjugated polymer nanomaterials
for ther-anostics. Acta Pharmacol Sin. 38:764–781. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu YJ and Chen F: pH-responsive
drug-delivery systems. Chem Asian J. 10:284–305. 2015. View Article : Google Scholar
|
|
28
|
Wang Z, Deng X, Ding J, Zhou W, Zheng X
and Tang G: Mechanisms of drug release in pH-sensitive micelles for
tumour targeted drug delivery system: A review. Int J Pharm.
535:253–260. 2018. View Article : Google Scholar
|
|
29
|
Lee ES, Oh KT, Kim D, Youn YS and Bae YH:
Tumor pH-responsive flower-like micelles of poly(L-lactic
acid)-b-poly(ethylene glycol)-b-poly(L-histidine). J Control
Release. 123:19–26. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Li F, Yi J, Gu C, Fan L, Qiao Y,
Tao Y, Cheng C and Wu H: Folate-decorated maleilated
pullulan-doxorubicin conjugate for active tumor-targeted drug
delivery. Eur J Pharm Sci. 42:517–526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
National Pharmacopoeia Committee:
Pharmacopoeia of People's Republic of China. China Medical Science
Press, Beijing Part. 2:9552015.
|
|
32
|
Zhou Q, Hou Y, Zhang L, Wang J, Qiao Y,
Guo S, Fan L, Yang T, Zhu L and Wu H: Dual-pH sensitive
charge-reversal nanocomplex for tumor-targeted drug delivery with
enhanced anticancer activity. Theranostics. 7:1806–1819. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mintzer MA and Simanek EE: Nonviral
vectors for gene delivery. Chem Rev. 109:259–302. 2009. View Article : Google Scholar
|
|
34
|
Aoshima Y, Hokama R, Sou K, Sarker SR,
Iida K, Nakamura H, Inoue T and Takeoka S: Cationic amino acid
based lipids as effective nonviral Gene delivery vectors for
primary cultured neurons. ACS Chem Neurosci. 4:1514–1519. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao G, Long L, Zhang L, Peng M, Cui T,
Wen X, Zhou X, Sun L and Che L: Smart pH-sensitive nanoassemblies
with cleavable PEGylation for tumor targeted drug delivery. Sci
Rep. 7:33832017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu Y, Li D, Guo X, Xu H, Li Z, Zhang Y,
Song C, Fan R, Tang X and Zhang Z: A pH-responsive prodrug delivery
system of 10-HCPT for controlled release and tumor targeting. Int J
Nanomedicine. 12:2227–2242. 2017. View Article : Google Scholar : PubMed/NCBI
|
